Read + Share
Moura FA, Berg DD, Bellavia A, Dwyer JP, et al. Risk Assessment of Kidney Disease Progression and Efficacy of SGLT2 Inhibition in
Patients With Type 2 Diabetes. Diabetes Care 2023 Aug 9:dc230492. doi: 10.2337/dc23-0492.
PMID: 37556796
|
 |
|
Moura FA, Berg DD, Bellavia A, Dwyer JP, et al. Risk Assessment of Kidney Disease Progression and Efficacy of SGLT2 Inhibition in
Patients With Type 2 Diabetes. Diabetes Care 2023 Aug 9:dc230492. doi: 10.2337/dc23-0492.
PMID: 37556796
|
|
|
|